1. Effect of food on the pharmacokinetics of TAS‐102 and its efficacy and safety in patients with advanced solid tumors. Issue 5 (28th March 2016) Authors: Yoshino, Takayuki; Kojima, Takashi; Bando, Hideaki; Yamazaki, Tomoko; Naito, Yoichi; Mukai, Hirofumi; Fuse, Nozomu; Goto, Koichi; Ito, Yuko; Doi, Toshihiko; Ohtsu, Atsushi Journal: Cancer science Issue: Volume 107:Issue 5(2016) Page Start: 659 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Guidelines for clinical evaluation of anti‐cancer drugs. Issue 7 (8th June 2021) Authors: Minami, Hironobu; Kiyota, Naomi; Kimbara, Shiro; Ando, Yuichi; Shimokata, Tomoya; Ohtsu, Atsushi; Fuse, Nozomu; Kuboki, Yasutoshi; Shimizu, Toshio; Yamamoto, Noboru; Nishio, Kazuto; Kawakami, Yutaka; Nihira, Shin‐ichi; Sase, Kazuhiro; Nonaka, Takahiro; Takahashi, Hideaki; Komori, Yukiko; Kiyohara... Journal: Cancer science Issue: Volume 112:Issue 7(2021) Page Start: 2563 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Pharmacokinetics, safety, and efficacy of FOLFIRI plus bevacizumab in Japanese colorectal cancer patients with UGT1A1 gene polymorphisms. (2nd January 2014) Authors: Suenaga, Mitsukuni; Fuse, Nozomu; Yamaguchi, Tatsuro; Yamanaka, Yasuhiro; Motomura, Shigeki; Matsumoto, Hiroshi; Hamamoto, Yasuo; Mizunuma, Nobuyuki; Doi, Toshihiko; Hatake, Kiyohiko; Iwasaki, Junko; Ohtsu, Atsushi Journal: Journal of clinical pharmacology Issue: Volume 54:Number 5(2014:May) Page Start: 495 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Phase I study of LY2603618, a CHK1 inhibitor, in combination with gemcitabine in Japanese patients with solid tumors. Issue 10 (November 2015) Authors: Doi, Toshihiko; Yoshino, Takayuki; Shitara, Kohei; Matsubara, Nobuaki; Fuse, Nozomu; Naito, Yoichi; Uenaka, Kazunori; Nakamura, Takashi; Hynes, Scott M.; Lin, Aimee Bence Journal: Anti-cancer drugs Issue: Volume 26:Issue 10(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Phase I study of LY2603618, a CHK1 inhibitor, in combination with gemcitabine in Japanese patients with solid tumors. Issue 10 (November 2015) Authors: Doi, Toshihiko; Yoshino, Takayuki; Shitara, Kohei; Matsubara, Nobuaki; Fuse, Nozomu; Naito, Yoichi; Uenaka, Kazunori; Nakamura, Takashi; Hynes, Scott M.; Lin, Aimee Bence Journal: Anti-cancer drugs Issue: Volume 26:Issue 10(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Phase I/II trial of chemoradiotherapy with concurrent S‐1 and cisplatin for clinical stage II/III esophageal carcinoma (JCOG 0604). Issue 10 (21st September 2015) Authors: Tahara, Makoto; Fuse, Nozomu; Mizusawa, Junki; Sato, Akihiro; Nihei, Keiji; Kanato, Keisuke; Kato, Ken; Yamazaki, Kentaro; Muro, Kei; Takaishi, Hiromasa; Boku, Narikazu; Ohtsu, Atsushi Journal: Cancer science Issue: Volume 106:Issue 10(2015:Oct.) Page Start: 1414 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Phase II study of cetuximab plus S-1/cisplatin therapy in Japanese patients with advanced gastric cancer. (10th February 2021) Authors: Yamaguchi, Kensei; Fuse, Nozomu; Komatsu, Yoshito; Fujii, Hirofumi; Hironaka, Shuichi; Omuro, Yasushi; Muro, Kei; Yasui, Hirofumi; Ueda, Shinya; Nishina, Tomohiro; Watanabe, Morihiro; Ohtsu, Atsushi Journal: Japanese journal of clinical oncology Issue: Volume 51:Number 6(2021) Page Start: 879 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Rationale and design of the BRAVERY study (EPOC1701): a multicentre phase II study of eribulin in patients with BRAF V600E mutant metastatic colorectal cancer. Issue 6 (13th November 2019) Authors: Masuishi, Toshiki; Taniguchi, Hiroya; Kotani, Daisuke; Bando, Hideaki; Komatsu, Yoshito; Shinozaki, Eiji; Nakajima, Takako Eguchi; Satoh, Taroh; Nishina, Tomohiro; Esaki, Taito; Wakabayashi, Masashi; Nomura, Shogo; Takahashi, Koji; Ono, Hiromi; Hirano, Nami; Fujishiro, Noriko; Fuse, Nozomu; Sato,... Journal: ESMO open Issue: Volume 4:Issue 6(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Sex differences in the safety of S‐1 plus oxaliplatin and S‐1 plus cisplatin for patients with metastatic gastric cancer. Issue 9 (23rd July 2019) Authors: Yamada, Yasuhide; Koizumi, Wasaburo; Nishikawa, Kazuhiro; Gotoh, Masahiro; Fuse, Nozomu; Sugimoto, Naotoshi; Nishina, Tomohiro; Amagai, Kenji; Chin, Keisho; Niwa, Yasumasa; Tsuji, Akihito; Imamura, Hiroshi; Tsuda, Masahiro; Yasui, Hirofumi; Fujii, Hirofumi; Yamaguchi, Kensei; Yasui, Hisateru; Hir... Journal: Cancer science Issue: Volume 110:Issue 9(2019) Page Start: 2875 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗